
The Hidden Growth Story: Biotech’s Quiet Resurgence
Biotechnology, despite its volatility, holds vast potential for transforming cancer treatments and healthcare. The COVID-19 pandemic thrust biotech into the spotlight, but the sector has since experienced stagnation in mergers, IPOs, and investments. JPMorgan and Goldman Sachs identify signals of a potential